{"id":446237,"title":"Guidance: COVID-19 drugs market authorization requirements - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T11:28:14.851000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-drugs.html?wbdisable=false","snippet":"Guidance for market authorization requirements for COVID-19 drugs: Overview Overview Rolling submissions and reviews Non-clinical and clinical requirements Quality and manufacturing requirements Labelling and post-market requirements Communications and transparency Download the…","rawSnapshotUrl":"/api/snapshots/raw/446237","browseUrl":"https://replay.healtharchive.ca/job-6/20260103112814/https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-drugs.html?wbdisable=false#ha_snapshot=446237","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}